BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29755855)

  • 21. QRISK3-based analysis of cardiovascular risk factors in patients with long-term but well-controlled systemic lupus erythematosus.
    Wang SL; Li W; Li TF; Liang X; Yan YL; Liu SY
    Am J Transl Res; 2022; 14(5):3247-3260. PubMed ID: 35702101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of periapical abscesses in patients with systemic lupus erythematosus.
    Rotstein I; Katz J
    Spec Care Dentist; 2022 Jan; 42(1):15-19. PubMed ID: 34240444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential impact of disease activity and damage on health-related quality of life in patients with systemic lupus erythematosus.
    Riaz MM; Shen L; Lateef A; Cho J
    Lupus; 2022 Aug; 31(9):1121-1126. PubMed ID: 35676227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged clinical remission and low disease activity statuses are associated with better quality of life in systemic lupus erythematosus.
    Poomsalood N; Narongroeknawin P; Chaiamnuay S; Asavatanabodee P; Pakchotanon R
    Lupus; 2019 Sep; 28(10):1189-1196. PubMed ID: 31307256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health-related quality of life in Chinese SLE patients: evidence from 1568 SLE patients and 2610 healthy controls.
    Wang YH; Sun HY; Liu YQ; Gong XY; Xu Y; Zong QQ; Yu GH; Hu WQ; Zhai CX; Wang LL; Yan ZY; Zhang TY; Cai J; Li M; Chen YF; Wang F; Zou YF
    Qual Life Res; 2024 Jan; 33(1):207-218. PubMed ID: 37824058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-nucleotide polymorphisms and haplotype of CYP2E1 gene associated with systemic lupus erythematosus in Chinese population.
    Liao LH; Zhang H; Lai MP; Chen SL; Wu M; Shen N
    Arthritis Res Ther; 2011 Jan; 13(1):R11. PubMed ID: 21281483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life?
    Jolly M; Utset TO
    Lupus; 2004; 13(12):924-6. PubMed ID: 15645747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Chinese version of the SLEQOL is a reliable assessment of health-related quality of life in Han Chinese patients with systemic lupus erythematosus.
    Jiang HZ; Lin ZG; Li HJ; -Du Q; -Tian W; Wang SY; Guan SQ; Mei YF
    Clin Rheumatol; 2018 Jan; 37(1):151-160. PubMed ID: 29168029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).
    Chaigne B; Chizzolini C; Perneger T; Trendelenburg M; Huynh-Do U; Dayer E; Stoll T; von Kempis J; Ribi C;
    BMC Immunol; 2017 Mar; 18(1):17. PubMed ID: 28351341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of belimumab therapy on the quality of life in patients with systemic lupus erythematosus: A cohort study.
    Prete M; Susca N; Leone P; De Giacomo A; Bray A; Brunori G; Favoino E; Perosa F; Racanelli V
    Lupus; 2023 Nov; 32(13):1528-1535. PubMed ID: 37903488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression, Anxiety and Disease-Related Variables and Quality of Life Among Individuals With Systemic Lupus Erythematosus Living in Kermanshah Province, Iran.
    Shakeri H; Arman F; Hossieni M; Omrani HR; Vahdani A; Shakeri J
    Iran Red Crescent Med J; 2015 Dec; 17(12):e31047. PubMed ID: 26756021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cosmetic camouflage improves health-related quality of life in women with systemic lupus erythematosus and permanent skin damage: A controlled intervention study.
    Oliveira FAP; Santos FMMD; Dias AFMP; Neiva CLS; Telles RW; Lanna CCD
    Lupus; 2020 Oct; 29(11):1438-1448. PubMed ID: 32757736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population.
    Mohammadi S; Saghaeian Jazi M; Zare Ebrahimabad M; Eghbalpour F; Abdolahi N; Tabarraei A; Yazdani Y
    Int J Immunogenet; 2019 Feb; 46(1):20-30. PubMed ID: 30430731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
    Jüptner M; Flachsbart F; Caliebe A; Lieb W; Schreiber S; Zeuner R; Franke A; Schröder JO
    Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The quality of life in Chinese patients with systemic lupus erythematosus is associated with disease activity and psychiatric disorders: a path analysis.
    Shen B; Feng G; Tang W; Huang X; Yan H; He Y; Chen W; Da Z; Liu H; Gu Z
    Clin Exp Rheumatol; 2014; 32(1):101-7. PubMed ID: 24029416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of functional polymorphisms in interferon regulatory factor 2 (IRF2) with susceptibility to systemic lupus erythematosus: a case-control association study.
    Kawasaki A; Furukawa H; Nishida N; Warabi E; Kondo Y; Ito S; Matsumoto I; Kusaoi M; Amano H; Suda A; Nagaoka S; Setoguchi K; Nagai T; Hirohata S; Shimada K; Sugii S; Okamoto A; Chiba N; Suematsu E; Ohno S; Katayama M; Okamoto A; Kono H; Tokunaga K; Takasaki Y; Hashimoto H; Sumida T; Tohma S; Tsuchiya N
    PLoS One; 2014; 9(10):e109764. PubMed ID: 25285625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of novel polymorphisms in TMEM39A gene with systemic lupus erythematosus in a Chinese Han population.
    Cai X; Huang W; Liu X; Wang L; Jiang Y
    BMC Med Genet; 2017 Apr; 18(1):43. PubMed ID: 28427360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: a longitudinal study.
    Louthrenoo W; Kasitanon N; Morand E; Kandane-Rathnayake R
    Arthritis Res Ther; 2020 Jan; 22(1):8. PubMed ID: 31924267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Belimumab for systemic lupus erythematosus.
    Singh JA; Shah NP; Mudano AS
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD010668. PubMed ID: 33631841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.